| TDI |
Figure TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006
Part (i) Percentage distribution by primary drug
|
figure |
| TDI |
Figure TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006
Part (ii) Numbers of clients by primary drug
|
figure |
| TDI |
Figure TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2006 in 24 EU Member States
Part (i) New clients
|
figure |
| TDI |
Figure TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2006 in 24 EU Member States
Part (ii) All clients
|
figure |
| TDI |
Figure TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2006
Part (i) Percentage distribution by primary drug
|
figure |
| TDI |
Figure TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2006
Part (ii) Numbers of clients by primary drug
|
figure |
| TDI |
Figure TDI-6. New and all outpatient clients by age group in 2006 for those countries supplying data
|
figure |
| TDI |
Figure TDI-7. New outpatient clients injecting opioid as primary drug from 2003 to 2006 in 13 countries supplying data
|
figure |
| TDI |
Figure TDI-11. Clients entering first treatment, all clients entering treatment, total clients in treatment, summary of nine EU countries reporting in 2006
Part (i) Number of clients in treatment
|
figure |
| TDI |
Figure TDI-11. Clients entering first treatment, all clients entering treatment, total clients in treatment, summary of nine EU countries reporting in 2006
Part (ii) Percentage of clients in treatment with opioids, cannabis or other drugs as primary drugs
|
figure |